These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 25337244)

  • 1. Expression of Yes-associated protein (YAP) in breast phyllodes tumor.
    Kim SK; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(9):5997-6005. PubMed ID: 25337244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Yes-associated protein (YAP) is differentially expressed in tumor and stroma according to the molecular subtype of breast cancer.
    Kim SK; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2014; 7(6):3224-34. PubMed ID: 25031743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of YES-associated protein (YAP) and its clinical significance in breast cancer tissues.
    Cao L; Sun PL; Yao M; Jia M; Gao H
    Hum Pathol; 2017 Oct; 68():166-174. PubMed ID: 28899737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cancer stem cell markers in breast phyllodes tumor.
    Kim SI; Koo JS
    Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor II messenger RNA-binding protein-3 is an indicator of malignant phyllodes tumor of the breast.
    Takizawa K; Yamamoto H; Taguchi K; Ohno S; Tokunaga E; Yamashita N; Kubo M; Nakamura M; Oda Y
    Hum Pathol; 2016 Sep; 55():30-8. PubMed ID: 27137988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations of epithelial c-kit expression in phyllodes tumours of the breast.
    Tawasil J; Go EM; Tsang JY; Ni YB; Ko CW; Tse GM
    J Clin Pathol; 2015 Oct; 68(10):808-11. PubMed ID: 26056158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Yes-associated protein (YAP) in metastatic breast cancer.
    Kim HM; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2015; 8(9):11248-57. PubMed ID: 26617849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of EMP1, EMP2, and EMP3 in breast phyllodes tumors.
    Cha YJ; Koo JS
    PLoS One; 2020; 15(8):e0238466. PubMed ID: 32857809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yes-associated protein expression is a predictive marker for recurrence of hepatocellular carcinoma after liver transplantation.
    Li H; Wang S; Wang G; Zhang Z; Wu X; Zhang T; Fu B; Chen G
    Dig Surg; 2014; 31(6):468-78. PubMed ID: 25632982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of phyllodes tumor recurrence according to the histologic grade.
    Kim S; Kim JY; Kim DH; Jung WH; Koo JS
    Breast Cancer Res Treat; 2013 Oct; 141(3):353-63. PubMed ID: 24062207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular classification of breast phyllodes tumors: validation of the histologic grading scheme and insights into malignant progression.
    Ang MK; Ooi AS; Thike AA; Tan P; Zhang Z; Dykema K; Furge K; Teh BT; Tan PH
    Breast Cancer Res Treat; 2011 Sep; 129(2):319-29. PubMed ID: 20945089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of lipid metabolism-related proteins in breast phyllodes tumors.
    Jung YY; Lee YK; Koo JS
    Neoplasma; 2016; 63(2):254-62. PubMed ID: 26774147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2005 Galloway Memorial Lecture: Breast phyllodes tumours--morphology and beyond.
    Tan PH
    Ann Acad Med Singap; 2005 Dec; 34(11):671-7. PubMed ID: 16453039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The expression of glutamine-metabolism-related proteins in breast phyllodes tumors.
    Kim S; Jung WH; Koo JS
    Tumour Biol; 2013 Oct; 34(5):2683-9. PubMed ID: 23636801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of Yes-associated protein and phosphorylated Yes-associated protein is correlated with expression of Ki-67 and phospho-ERK in colorectal adenocarcinoma.
    Kim DH; Kim SH; Lee OJ; Huang SM; Kwon JL; Kim JM; Kim JY; Seong IO; Song KS; Kim KH
    Histol Histopathol; 2013 Nov; 28(11):1483-90. PubMed ID: 23673988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecules involved in epithelial-mesenchymal transition and epithelial-stromal interaction in phyllodes tumors: implications for histologic grade and prognosis.
    Kwon JE; Jung WH; Koo JS
    Tumour Biol; 2012 Jun; 33(3):787-98. PubMed ID: 22203494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of autophagy-related proteins in phyllodes tumor.
    Kim SK; Jung WH; Koo JS
    Int J Clin Exp Pathol; 2013; 6(10):2145-56. PubMed ID: 24133593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of microRNA20b is associated with malignant clinicopathological features and poor prognosis in breast phyllodes tumor.
    Lei T; Yin L; Zhang H; Wei B; Chen H; Pu T; Yang L; Ye F; Zhang Z; Bu H
    Int J Clin Oncol; 2020 Dec; 25(12):2025-2034. PubMed ID: 32803488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer.
    Di Benedetto A; Mottolese M; Sperati F; Ercolani C; Di Lauro L; Pizzuti L; Vici P; Terrenato I; Shaaban AM; Humphries MP; Sundara-Rajan S; Barba M; Speirs V; De Maria R; Maugeri-Saccà M
    J Cell Physiol; 2017 Aug; 232(8):2246-2252. PubMed ID: 27987320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cells in phyllodes tumors of the breast are enriched for EZH2 and stem cell marker expression.
    Zhang Y; Liss AL; Chung E; Pierce LJ; Kleer CG
    Breast Cancer Res Treat; 2016 Jul; 158(1):21-28. PubMed ID: 27290698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.